NEW WELLLINK
871634
VIBO
871245
MTD
835579
4
REFORMER
833030
5
Hunan Sundy Science And Technology
300515
US Stock MarketDetailed Quotes
ITOS ITeos Therapeutics
- 7.050
- -0.045-0.63%
Close Mar 7 16:00 ET
- 7.050
- 0.0000.00%
Post 16:00 ET
269.27MMarket Cap-2.12P/E (TTM)
7.315High7.010Low287.49KVolume7.060Open7.095Pre Close2.05MTurnover0.99%Turnover RatioLossP/E (Static)38.19MShares18.75052wk High0.46P/B205.53MFloat Cap6.67052wk Low--Dividend TTM29.15MShs Float52.430Historical High--Div YieldTTM4.30%Amplitude6.670Historical Low7.114Avg Price1Lot Size
Trending Stocks
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!
ITeos Therapeutics Stock Forum
iTeos Therapeutics Presents Interim A2A-005 Clinical Trial Data, Translational, and Preclinical Data from Inupadenant at ESMO Immuno-Oncology Congress
Thursday, 12th December at 8:55 am
- Inupadenant + carboplatin/pemetrexed in Phase 2 A2A-005 trial demonstrated a 63.9% overall response rate (ORR) and a median PFS of 7.7 months for all evaluable patients across the cohorts
- Recommended Phase 2 dose (RP2D) of inupadenant 80mg + carboplatin/pemetrexed demonstrat...
$ITeos Therapeutics (ITOS.US)$
$Montrose Environmental (MEG.US)$
$Nurix Therapeutics (NRIX.US)$
$Pearson (PSO.US)$
$UnitedHealth (UNH.US)$
$Option Care Health (OPCH.US)$
$Procter & Gamble (PG.US)$
$Montrose Environmental (MEG.US)$
$Nurix Therapeutics (NRIX.US)$
$Datadog (DDOG.US)$
$Pearson (PSO.US)$
$Procter & Gamble (PG.US)$
$Option Care Health (OPCH.US)$
$UnitedHealth (UNH.US)$
No comment yet